Corcept Therapeutics Incorporated EPS (Earnings per Share) 2000–2025
Corcept Therapeutics Incorporated reported $0.82 of earnings per share for fiscal 2025. That was 33.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -3.5%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $0.82 | -33.3% |
| FY 2024 | $1.23 | +30.9% |
| FY 2023 | $0.94 | +8.0% |
| FY 2022 | $0.87 | -2.2% |
| FY 2021 | $0.89 | +4.7% |
| FY 2020 | $0.85 | +10.4% |
| FY 2019 | $0.77 | +28.3% |
| FY 2018 | $0.60 | -42.3% |
| FY 2017 | $1.04 | +1385.7% |
| FY 2016 | $0.07 | +216.7% |
| FY 2015 | $-0.06 | — |
| FY 2014 | $0.00 | — |
| FY 2013 | $0.00 | — |
| FY 2012 | $0.00 | — |
| FY 2011 | $0.00 | — |
| FY 2010 | $0.00 | — |
| FY 2009 | $0.00 | — |
| FY 2008 | $0.00 | — |
| FY 2007 | $0.00 | — |
| FY 2006 | $0.00 | — |
| FY 2005 | $0.00 | — |
| FY 2004 | $0.00 | — |
| FY 2003 | $0.00 | — |
| FY 2002 | $0.00 | — |
| FY 2001 | $0.00 | — |
| FY 2000 | $0.00 | — |
Source: Corcept Therapeutics Incorporated SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CORT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Corcept Therapeutics Incorporated reported $0.82 of earnings per share for fiscal 2025. That was 33.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -3.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Corcept Therapeutics Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCorcept Therapeutics Incorporated — frequently asked questions
What is Corcept Therapeutics Incorporated's earnings per share?
Corcept Therapeutics Incorporated (CORT) reported earnings per share of $0.82 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Corcept Therapeutics Incorporated's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.